{
    "componentChunkName": "component---src-templates-docs-js",
    "path": "/",
    "result": {"data":{"site":{"siteMetadata":{"title":"LTA Antistollingszorg"}},"mdx":{"fields":{"id":"c56a825a-0c61-5763-a332-00fcad99b7de","title":"Welkom!","slug":"/"},"body":"var _excluded = [\"components\"];\n\nfunction _extends() { _extends = Object.assign ? Object.assign.bind() : function (target) { for (var i = 1; i < arguments.length; i++) { var source = arguments[i]; for (var key in source) { if (Object.prototype.hasOwnProperty.call(source, key)) { target[key] = source[key]; } } } return target; }; return _extends.apply(this, arguments); }\n\nfunction _objectWithoutProperties(source, excluded) { if (source == null) return {}; var target = _objectWithoutPropertiesLoose(source, excluded); var key, i; if (Object.getOwnPropertySymbols) { var sourceSymbolKeys = Object.getOwnPropertySymbols(source); for (i = 0; i < sourceSymbolKeys.length; i++) { key = sourceSymbolKeys[i]; if (excluded.indexOf(key) >= 0) continue; if (!Object.prototype.propertyIsEnumerable.call(source, key)) continue; target[key] = source[key]; } } return target; }\n\nfunction _objectWithoutPropertiesLoose(source, excluded) { if (source == null) return {}; var target = {}; var sourceKeys = Object.keys(source); var key, i; for (i = 0; i < sourceKeys.length; i++) { key = sourceKeys[i]; if (excluded.indexOf(key) >= 0) continue; target[key] = source[key]; } return target; }\n\n/* @jsxRuntime classic */\n\n/* @jsx mdx */\nvar _frontmatter = {\n  \"title\": \"Welkom!\",\n  \"metaTitle\": \"Introductie\",\n  \"metaDescription\": \"De LTA antistollingszorg geeft richting aan de samenwerking tussen de medisch specialist, huisarts, trombosedienst, openbaar apotheker, specialist ouderengeneeskunde, tandartsen en mondhygiënisten op het gebied van antitrombotica.\",\n  \"date\": \"21-10-2025\",\n  \"type\": \"\",\n  \"nextUrl\": \"/inleiding\",\n  \"nextText\": \"Inleiding\",\n  \"previousUrl\": \"\",\n  \"previousText\": \"\"\n};\n\nvar makeShortcode = function makeShortcode(name) {\n  return function MDXDefaultShortcode(props) {\n    console.warn(\"Component \" + name + \" was not imported, exported, or provided by MDXProvider as global scope\");\n    return mdx(\"div\", props);\n  };\n};\n\nvar Card = makeShortcode(\"Card\");\nvar LinkOutlined = makeShortcode(\"LinkOutlined\");\nvar layoutProps = {\n  _frontmatter: _frontmatter\n};\nvar MDXLayout = \"wrapper\";\nreturn function MDXContent(_ref) {\n  var components = _ref.components,\n      props = _objectWithoutProperties(_ref, _excluded);\n\n  return mdx(MDXLayout, _extends({}, layoutProps, props, {\n    components: components,\n    mdxType: \"MDXLayout\"\n  }), mdx(\"h2\", null, \"Landelijke Transmurale Afspraak (LTA) Antistollingszorg\"), mdx(\"p\", null, \"De landelijke transmurale afspraak (LTA) antistollingszorg geeft richting aan de \", mdx(\"em\", {\n    parentName: \"p\"\n  }, \"samenwerking\"), \" tussen:\"), mdx(\"ul\", null, mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"de medisch specialist\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"huisarts\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"trombosedienst\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"openbaar apotheker\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"specialist ouderengeneeskunde\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"tandartsen en mondhygi\\xEBnisten\")), mdx(\"hr\", null), mdx(\"p\", null, \"Op deze website vindt u onder meer informatie over het voorschrijven en de follow-up\\nvan antitrombotica, periprocedureel beleid en het beleid bij bloedingen. Ook vindt\\nu op deze website informatie over onderwerpen die belangrijk zijn in de communicatie\\nmet pati\\xEBnten. Voor de onderdelen periprocedureel beleid en beleid bij bloedingen\\nzijn beslisbomen ontwikkeld.\"), mdx(NotifyIE, {\n    mdxType: \"NotifyIE\"\n  }), mdx(Divider, {\n    mdxType: \"Divider\"\n  }), mdx(Row, {\n    gutter: 16,\n    mdxType: \"Row\"\n  }, mdx(Col, {\n    span: 8,\n    mdxType: \"Col\"\n  }, mdx(Card, {\n    title: \"Initiatief\",\n    size: \"small\",\n    cover: mdx(\"img\", {\n      alt: \"Nederlandse Internisten Vereniging\",\n      src: \"/img/logo-niv.png\",\n      style: {\n        width: \"100%\",\n        height: \"150px\",\n        objectFit: \"contain\",\n        padding: \"10%\",\n        backgroundColor: \"#fafafa\"\n      }\n    }),\n    mdxType: \"Card\"\n  }, mdx(\"h4\", null, \"Nederlandse Internisten Vereniging\"), mdx(\"a\", {\n    href: \"https://internisten.nl?utm_source=lta-antistollingszorg\",\n    target: \"_blank\",\n    rel: \"noreferrer noopener\"\n  }, mdx(LinkOutlined, {\n    mdxType: \"LinkOutlined\"\n  })))), mdx(Col, {\n    span: 8,\n    mdxType: \"Col\"\n  }, mdx(Card, {\n    title: \"Ondersteuning\",\n    size: \"small\",\n    cover: mdx(\"img\", {\n      alt: \"Kennisinstituut van de Federatie Medisch Specialisten\",\n      src: \"/img/logo-fms.png\",\n      style: {\n        width: \"100%\",\n        height: \"150px\",\n        objectFit: \"contain\",\n        padding: \"10%\",\n        backgroundColor: \"#fafafa\"\n      }\n    }),\n    mdxType: \"Card\"\n  }, mdx(\"h4\", null, \"Kennisinstituut van de Federatie Medisch Specialisten\"), mdx(\"a\", {\n    href: \"https://www.demedischspecialist.nl?utm_source=lta-antistollingszorg\",\n    target: \"_blank\",\n    rel: \"noreferrer noopener\"\n  }, mdx(LinkOutlined, {\n    mdxType: \"LinkOutlined\"\n  })))), mdx(Col, {\n    span: 8,\n    mdxType: \"Col\"\n  }, mdx(Card, {\n    title: \"Financiering\",\n    size: \"small\",\n    mdxType: \"Card\"\n  }, mdx(\"h4\", null, \"Stichting Kwaliteitsgelden Medisch Specialisten (SKMS)\"), mdx(\"a\", {\n    href: \"https://www.demedischspecialist.nl/onderwerp/skms?utm_source=lta-antistollingszorg\",\n    target: \"_blank\",\n    rel: \"noreferrer noopener\"\n  }, mdx(LinkOutlined, {\n    mdxType: \"LinkOutlined\"\n  }))))), mdx(Divider, {\n    mdxType: \"Divider\"\n  }), mdx(\"h2\", null, \"In samenwerking met\"), mdx(Row, {\n    gutter: 16,\n    mdxType: \"Row\"\n  }, mdx(Col, {\n    span: 8,\n    mdxType: \"Col\"\n  }, mdx(Card, {\n    size: \"small\",\n    cover: mdx(\"img\", {\n      alt: \"Nederlandse Vereniging voor Cardiologie\",\n      src: \"/img/logo-nvvc.png\",\n      style: {\n        width: '100%',\n        height: '100px',\n        objectFit: 'contain',\n        padding: \"10%\",\n        backgroundColor: \"#fafafa\"\n      }\n    }),\n    mdxType: \"Card\"\n  }, mdx(\"h4\", null, \"Nederlandse Vereniging voor Cardiologie\"), mdx(\"a\", {\n    href: \"https://www.nvvc.nl?utm_source=lta-antistollingszorg\",\n    target: \"_blank\",\n    rel: \"noreferrer noopener\"\n  }, mdx(LinkOutlined, {\n    mdxType: \"LinkOutlined\"\n  })))), mdx(Col, {\n    span: 8,\n    mdxType: \"Col\"\n  }, mdx(Card, {\n    size: \"small\",\n    cover: mdx(\"img\", {\n      alt: \"Nederlands Huisartsen Genootschap\",\n      src: \"/img/logo-nhg.png\",\n      style: {\n        width: '100%',\n        height: '100px',\n        objectFit: 'contain',\n        padding: \"10%\",\n        backgroundColor: \"#fafafa\"\n      }\n    }),\n    mdxType: \"Card\"\n  }, mdx(\"h4\", null, \"Nederlands Huisartsen Genootschap\"), mdx(\"a\", {\n    href: \"https://www.nhg.org?utm_source=lta-antistollingszorg\",\n    target: \"_blank\",\n    rel: \"noreferrer noopener\"\n  }, mdx(LinkOutlined, {\n    mdxType: \"LinkOutlined\"\n  })))), mdx(Col, {\n    span: 8,\n    mdxType: \"Col\"\n  }, mdx(Card, {\n    size: \"small\",\n    cover: mdx(\"img\", {\n      alt: \"Harteraad\",\n      src: \"/img/logo-harteraad.png\",\n      style: {\n        width: '100%',\n        height: '100px',\n        objectFit: 'contain',\n        padding: \"10%\",\n        backgroundColor: \"#fafafa\"\n      }\n    }),\n    mdxType: \"Card\"\n  }, mdx(\"h4\", null, \"Harteraad\"), mdx(\"a\", {\n    href: \"https://www.harteraad.nl?utm_source=lta-antistollingszorg\",\n    target: \"_blank\",\n    rel: \"noreferrer noopener\"\n  }, mdx(LinkOutlined, {\n    mdxType: \"LinkOutlined\"\n  }))))));\n}\n;\nMDXContent.isMDXComponent = true;","tableOfContents":{"items":[{"url":"#landelijke-transmurale-afspraak-lta-antistollingszorg","title":"Landelijke Transmurale Afspraak (LTA) Antistollingszorg"},{"url":"#in-samenwerking-met","title":"In samenwerking met"}]},"parent":{"relativePath":"index.mdx"},"frontmatter":{"parent":null,"date":"21-10-2025","nextUrl":"/inleiding","nextText":"Inleiding","previousUrl":"","previousText":""}},"allMdx":{"edges":[{"node":{"fields":{"slug":"/afbakening","title":"Afbakening"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica","title":"Bloedingen onder antitrombotica"}}},{"node":{"fields":{"slug":"/colofon","title":"Colofon"}}},{"node":{"fields":{"slug":"/contact","title":"Contact"}}},{"node":{"fields":{"slug":"/inleiding","title":"Inleiding"}}},{"node":{"fields":{"slug":"/colofon/afkortingenlijst","title":"Afkortingenlijst"}}},{"node":{"fields":{"slug":"/communicatie-met-patienten/gezamenlijke-besluitvorming","title":"Gezamenlijke besluitvorming"}}},{"node":{"fields":{"slug":"/colofon/verantwoording","title":"Verantwoording"}}},{"node":{"fields":{"slug":"/communicatie-met-patienten/algemene-informatie","title":"Algemene informatie"}}},{"node":{"fields":{"slug":"/communicatie-met-patienten/informatievoorziening","title":"Informatievoorziening"}}},{"node":{"fields":{"slug":"/communicatie-met-patienten/therapietrouw","title":"Therapietrouw"}}},{"node":{"fields":{"slug":"/communicatie-met-patienten/veelgestelde-vragen-over-doacs","title":"Veelgestelde vragen over DOACs"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/algemene-informatie","title":"Algemene informatie"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/overzicht-periprocedureel-bloedingsrisico","title":"Overzicht periprocedureel bloedingsrisico"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/overzicht-trombo-embolie-risico","title":"Overzicht trombo-embolie risico"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/ernstige-bloedingen/algemene-informatie","title":"Algemene informatie"}}},{"node":{"fields":{"slug":"/voorschrijven-en-follow-up/algemene-informatie","title":"Algemene informatie"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/ernstige-bloedingen/beslisboom-doac-factor-xa-remmers-rivaroxaban-apixaban-edoxaban","title":"Beslisboom DOAC - factor Xa-remmers, Rivaroxaban, Apixaban, Edoxaban"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/niet-ernstige-bloedingen/beslisboom-beleid-bij-bloedingen-voor-de-huisarts","title":"Beslisboom Beleid bij bloedingen voor de huisarts"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/niet-ernstige-bloedingen/beslisboom-doac","title":"Beslisboom DOAC"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/niet-ernstige-bloedingen/beslisboom-vka","title":"Beslisboom VKA"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/doac/beslisboom-apixaban","title":"Beslisboom Apixaban"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/niet-ernstige-bloedingen/bloeding-onder-lmwh-ongefractioneerde-heparine","title":"Bloeding onder LMWH/ ongefractioneerde heparine"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/doac/beslisboom-rivaroxaban","title":"Beslisboom Rivaroxaban"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/tar/beslisboom-dapt-asa-en-prasugrel-clopidogrel-ticagrelor","title":"Beslisboom DAPT ASA en prasugrel, clopidogrel, ticagrelor"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/tar/beslisboom-dapt-asa-en-dipyridamol","title":"Beslisboom DAPT ASA en dipyridamol"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/tar/beslisboom-monotherapie-clopidogrel-of-asa","title":"Beslisboom monotherapie Clopidogrel of ASA"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/tar/minimale-duur-onderbreken-en-herstarten-dapt","title":"Minimale duur onderbreken en herstarten DAPT"}}},{"node":{"fields":{"slug":"/voorschrijven-en-follow-up/doac/follow-up-controles","title":"Follow-up controles"}}},{"node":{"fields":{"slug":"/voorschrijven-en-follow-up/doac/overzicht","title":"Overzicht"}}},{"node":{"fields":{"slug":"/voorschrijven-en-follow-up/lmwh/overzicht","title":"Overzicht"}}},{"node":{"fields":{"slug":"/voorschrijven-en-follow-up/tar/overzicht","title":"Overzicht"}}},{"node":{"fields":{"slug":"/voorschrijven-en-follow-up/tar/follow-up-controles","title":"Follow-up controles"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/doac/beslisboom-edoxaban","title":"Beslisboom Edoxaban"}}},{"node":{"fields":{"slug":"/voorschrijven-en-follow-up/vka/follow-up-controles","title":"Follow-up controles"}}},{"node":{"fields":{"slug":"/voorschrijven-en-follow-up/vka/overzicht","title":"Overzicht"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/ernstige-bloedingen/beslisboom-doac-dabigatran/schematisch","title":"Beslisboom DOAC- dabigatran"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/ernstige-bloedingen/beslisboom-tar/schematisch","title":"Beslisboom TAR"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/ernstige-bloedingen/beslisboom-vka/schematisch","title":"Beslisboom VKA"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/niet-ernstige-bloedingen/beslisboom-doac/schematisch","title":"Beslisboom DOAC"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/niet-ernstige-bloedingen/beslisboom-vka/schematisch","title":"Beslisboom VKA"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/doac/beslisboom-apixaban/schematisch","title":"Beslisboom Apixaban"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/niet-ernstige-bloedingen/beslisboom-tar/schematisch","title":"Beslisboom TAR"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/doac/beslisboom-dabigatran/schematisch","title":"Beslisboom Dabigatran"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/doac/beslisboom-rivaroxaban/schematisch","title":"Beslisboom Rivaroxaban"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/ernstige-bloedingen/beslisboom-doac-factor-xa-remmers-rivaroxaban-apixaban-edoxaban/schematisch","title":"Beslisboom DOAC - factor Xa-remmers, Rivaroxaban, Apixaban, Edoxaban"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/doac/beslisboom-edoxaban/schematisch","title":"Beslisboom Edoxaban"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/niet-ernstige-bloedingen/beslisboom-beleid-bij-bloedingen-voor-de-huisarts/schematisch","title":"Beslisboom Beleid bij bloedingen voor de huisarts"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/tar/beslisboom-dapt-asa-en-dipyridamol/schematisch","title":"Beslisboom DAPT ASA en dipyridamol"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/tar/beslisboom-monotherapie-clopidogrel-of-asa/schematisch","title":"Beslisboom monotherapie Clopidogrel of ASA"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/vka/beslisboom-vka/schematisch","title":"Beslisboom VKA"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/tar/beslisboom-dapt-asa-en-prasugrel-clopidogrel-ticagrelor/schematisch","title":"Beslisboom DAPT ASA en prasugrel, clopidogrel, ticagrelor"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/tar/dual-antiplatelet-therapy-dapt-behandeling","title":"Dual Antiplatelet Therapy (DAPT) behandeling"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/vka/aanbevelingen-overbrugging-en-herstarten-vka","title":"Aanbevelingen overbrugging en herstarten VKA"}}},{"node":{"fields":{"slug":"/voorschrijven-en-follow-up/lmwh/dosering-lmwh-bij-verminderde-nierfunctie","title":"Dosering LMWH bij verminderde nierfunctie"}}},{"node":{"fields":{"slug":"/voorschrijven-en-follow-up/hoog-complexe-antistolling","title":"Hoog complexe antistolling"}}},{"node":{"fields":{"slug":"/voorschrijven-en-follow-up/laag-complexe-antistolling","title":"Laag complexe antistolling"}}},{"node":{"fields":{"slug":"/literatuur","title":"Literatuur"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/ernstige-bloedingen/beslisboom-vka","title":"Beslisboom VKA"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/ernstige-bloedingen/beslisboom-doac-dabigatran","title":"Beslisboom DOAC - dabigatran"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/vka/beslisboom-vka","title":"Beslisboom VKA"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/extra-opmerkingen-tandheelkundige-ingrepen","title":"Extra opmerkingen tandheelkundige ingrepen"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/doac/beslisboom-dabigatran","title":"Beslisboom Dabigatran"}}},{"node":{"fields":{"slug":"/communicatie-met-patienten/veelgestelde-vragen-over-vka","title":"Veelgestelde vragen over VKA"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/ernstige-bloedingen/beslisboom-lmwh-ongefractioneerde-heparine/schematisch","title":"Beslisboom LMWH/ongefractioneerde heparine"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/ernstige-bloedingen/beslisboom-tar","title":"Beslisboom TAR"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/niet-ernstige-bloedingen/algemene-informatie","title":"Algemene informatie"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/niet-ernstige-bloedingen/beslisboom-lmwh-ongefractioneerde-heparine/schematisch","title":"Beslisboom LMWH/ongefractioneerde heparine"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/niet-ernstige-bloedingen/beslisboom-lmwh-ongefractioneerde-heparine","title":"Beslisboom LMWH/ongefractioneerde heparine"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/niet-ernstige-bloedingen/beslisboom-tar","title":"Beslisboom TAR"}}},{"node":{"fields":{"slug":"/changelog","title":"Changelog"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/ernstige-bloedingen/beslisboom-lmwh-ongefractioneerde-heparine","title":"Beslisboom LMWH/ongefractioneerde heparine"}}},{"node":{"fields":{"slug":"/","title":"Welkom!"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/extra-opmerkingen-endoscopische-ingrepen","title":"Extra opmerkingen endoscopische ingrepen"}}}]}},"pageContext":{"id":"c56a825a-0c61-5763-a332-00fcad99b7de"}},
    "staticQueryHashes": ["1620603387","2744294623","3578633366","3706406642","4066733661"]}